Open Call To Include New Beneficiaries Into The EUCAIM Consortium

Published on: April 19, 2024
Categories: News
The EUCAIM project is launching an open call for new beneficiaries to join the consortium. The objective of the EUCAIM open call is to:

i) onboard new cancer image data holders, increasing the geographic dimensions, data modalities or cancer targets, and 

ii) include new reliable AI algorithms trained on the cancer image data of the repository.

To reach the above objectives, the new beneficiaries will implement data incorporation, scientific and/or clinical use cases. A use case refers to a specific scenario or situation in which the Cancer Image Europe platform is used to address a real-life scientific or clinical question where access and re-use of large amounts of cancer data can improve patient outcomes.

The following use cases are accepted for this call:

  • Incorporation of large amounts of cancer imaging data into the Cancer Image Europe platform for further re-use, which can be leveraged to address relevant clinical questions (either into the central repository or through the federation of local repositories)
  • Development, training, benchmarking and/or validation of AI algorithms
  • Clinical use cases addressing a specific question (e.g. identification of imaging biomarkers)

The full call text can be found on the Cancer Image Europe website:

Deadline for submission is 10 June 2024.

Applicants can contact for further details and assistance during the application process.

Application form

Webinar Alert: Learn More About EUCAIM’s Open Call For New Beneficiaries!

EUCAIM is excited to announce an upcoming webinar dedicated to providing more insights into our abovementioned open call for new beneficiaries. This webinar presents a unique opportunity for individuals and organisations interested in contributing to cutting-edge cancer research and innovation to learn about joining the EUCAIM consortium. The open call is geared towards incorporating new data into the EUCAIM platform and training, benchmarking, and validating AI algorithms for cancer imaging. During the webinar, participants will gain a comprehensive understanding of the open call process, including eligibility criteria, application requirements, application procedure, etc. Attendees will also have the opportunity to ask questions and interact with members of the EUCAIM team.

Don’t miss out on this valuable opportunity to learn more about the EUCAIM open call and how you can contribute to shaping the future of cancer imaging research. Mark your calendars and register now to secure your spot!

Date: April 26th, 2024.

Time: 10:00-11.30 AM CEST.

Location: Online webinar – Link will be sent to all registered participants in due course.

Webinar registration:



AI in PCa imaging : The current status and future perspectives

AI in PCa imaging : The current status and future perspectives

Ιn recent years, magnetic resonance imaging (MRI) has transformed the prostate cancer (PCa) diagnostic pathway, based on the evidence of multiple high-level evidence studies (refs 4M, MRI first, and PROMIS). Taken together, the evidence indicates that prostate MRI...

Third Dissemination Event of the ProCAncer-I Project in Athens

Third Dissemination Event of the ProCAncer-I Project in Athens

ProCAncer-I will be organising the 3rd Dissemination Event at the 21st IEEE International Symposium on Biomedical Imaging, which will be held in Athens, Greece, May 27-30, 2024. ProCAncer-I will organise the Workshop “Integrating imaging Data and AI models for...

ProCAncer-I at the ECR 2024 in Vienna

ProCAncer-I at the ECR 2024 in Vienna

A great congress once more! Artificial Intelligence (AI) took the spotlight at the European Radiology Congress (ECR) held at the Austria Center Vienna from February 28 to March 3. Under the theme of 'Next Generation Radiology,' cutting-edge technologies were...

Stay in touch!